Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion.
Where this comes from
- Record sourced from PubMed, PMID 31388012.
- Also identified by DOI 10.1038/s41467-019-11569-z and PMC identifier 6684632.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.